Malignant Hyperthermia: Skeletal Muscle Defect(s) Predisposing to Labile Ca2 + Regulation?

Abstract

Get full access to this article

View all access options for this article.

References

Kalow W. , Britt BA , Terseau ME , Haist C. : Metabolic error of muscle metabolism after recovery from malignant hyperthermia . Lancet 1970;2:895-898.

Ellis FR , Harriman Dgf , Keaney NP , et al: Halothane-induced muscle contracture as a cause of hyperpyrexia . Br J Anaesth 1971;43:721-722.

Nelson TE , Flewellen EH , Gloyna DF : Spectrum of susceptibility to malignant hyperthermia—diagnostic dilemma . Anesth Analg 1983;62:545-552.

Nelson TE : Malignant hyperthermia in dogs. J Am Vet Med Assoc 1991;198:989-994.

Fujii J. , Otsu K. , Zorzato F. , et al: Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 1991;253:448-451.

MacLennan DH , Duff C. , Zorzato F. , et al: Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 1990;343:559-561.

McCarthy TV , Healy Sjm , Heffron Jja , et al: Localization of the malignant hyperthermia susceptibility locus to human chromosome 19 of 12-13.2. Nature 1990;343:562.

Gillard EF , Otsu K. , Fujii J. , et al: A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 1991;11:543.

Fill M. , Stefani E. , Nelson TE : Abnormal human sarcoplasmic reticulum Ca2+ release channels in malignant hyperthermia skeletal muscle. Biophys J 1991 ;59:1085-1090.

10.

Fill M. , Coronado R. , Michelson JR , et al: Abnormal ryanodine receptor channels in malignant hyperthermia . Biophys J 1990;50:471-476.

11.

Nelson TE : Halothane effects on human malignant hyperthermia skeletal muscle single calcium-release channels in planar lipid bilayers. Anesthesiology 1992;76:588-595.

12.

Mickelson JR , Gallant EM , Litterer LA , et al: Enhanced Ca2+ induced release by isolated sarcoplasmic reticulum vesicles from malignant hyperthermia pig muscle. J Biol Chem 1988 ;263:9310-9315.

13.

Hawkes MJ , Nelson TE , Hamilton SL : [3H]-Ryanodine as a probe of changes in the functional state of the Ca2+ release channel in malignant hyperthermia. J Biol Chem 1992; 267:6702- 6709.

14.

Valdivia HH , Hogan K. , Coronado R. : Altered binding site for Ca2+ in the ryanodine receptor of human malignant hyperthermia. Am J Physiol 1991;261:C237-C245.

15.

Gallant EM : Porcine malignant hyperthermia: No role for plasmalemma depolarization . Muscle Nerve 1988;11:785-786.

16.

Lopez JR , Gerardi A. , Lopez MJ , Allen DD : Effects of dantrolene on myoplasmic free [Ca2+] measured in vivo in patients susceptible to malignant hyperthermia. Anesthesiology 1992;76:711-719.

17.

Wieland SJ , Fletcher JE , Rosenberg H. , Gong QH : Malignant hyperthermia: Slow sodium current in cultured human muscle cells . Am J Physiol 1989;257:C759.

18.

Ervasti JM , Claessens MT , Mickelson JR , Louis CF : Altered transverse tubule dihydropyridine receptor binding in malignant hyperthermia . J Biol Chem 1989;264:2711-2717.

19.

Mejia-Alvarez R. , Fill M. , Garcia J. , et al: Reduced transverse tubule Ca2+ currents in human malignant hyperthermia skeletal muscle. Biophys J 1991;59:271a.

20.

Adnet PJ , Krivosic-Harber RM , Adamantidis MM , et al: Effect of Bay K 8644 on the magnitude of isoflurane and halothane contractures of skeletal muscle from patients susceptible to malignant hyperthermia . Anesthesiology 1992;76:544-549.

21.

Frank JP , Harati Y. , Butler IJ , et al: Central core disease and malignant hyperthermia syndrome. Ann Neurol 1980;7:11-17.

22.

Denborough MA , Dennet X. , Anderson R. : Central core disease and malignant hyperpyrexia . Br Med J 1973 ;1:272-273.

23.

Kausch K. , Grimm T. , Janka M. , et al: Evidence for linkage of the central core disease locus to chromosome 19 g. J Neurol Sci 1990;98:549.

24.

King JO , Denborough MA : Anesthetic induced malignant hyperpyrexia in children. J Pediatr 1973:83:37-40.

25.

McPherson EW , Taylor CA Jr : The King syndrome: Malignant hyperthermia, myopathy, and multiple anomalies. Am J Med Genet 1981;8:159-165.

26.

Lingaraju N. , Rosenberg H. : Unexplained increases in serum creatine kinase levels: Its relation to malignant hyperthermia susceptibility . Anesth Analg 1991;72:702-705.